Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials GroupMalcolm J. Moore, Wendy R. Parulekar, Daniel de Castro et al.|Journal of Clinical Oncology|2007Cited by 3.9k
Revision of the American Joint Committee on Cancer Staging System for Breast CancerS. Eva Singletary, Frederick L. Greene, Craig Allred et al.|Journal of Clinical Oncology|2002Cited by 1.2k
Prognostic Factors in Breast CancerPatrick L. Fitzgibbons, Stuart J. Schnitt, David L. Page et al.|Archives of Pathology & Laboratory Medicine|2000Cited by 1.1k
Symptom Improvement in Lung Cancer Patients Treated With Erlotinib: Quality of Life Analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21Andrea Bezjak, Frances A. Shepherd, Dongsheng Tu et al.|Journal of Clinical Oncology|2006Cited by 295
Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging ManualS. Eva Singletary, Frederick L. Greene, Craig Allred et al.|Surgical Clinics of North America|2003Cited by 293